Shanghai Haohai Biological Tech Co Asset Resilience Ratio
Shanghai Haohai Biological Tech Co asset resilience ratio. Shanghai Haohai Biological Tech Co (688366) has an Asset Resilience Ratio of 1.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Haohai Biological Tech Co defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shanghai Haohai Biological Tech Co (2012–2024)
Asset resilience ratio of Shanghai Haohai Biological Tech Co from 2012 to 2024. This chart shows how Shanghai Haohai Biological Tech Co's Asset Resilience Ratio has changed over time. Read debt load of Shanghai Haohai Biological Tech Co for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Haohai Biological Tech Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Haohai Biological Tech Co (688366) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥107.18 Million | 1.51% |
| Total Liquid Assets | CN¥107.18 Million | 1.51% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Haohai Biological Tech Co maintains only 1.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Haohai Biological Tech Co Industry Peers by Asset Resilience Ratio
Compare Shanghai Haohai Biological Tech Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 15.95% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
Summit Therapeutics PLC
NASDAQ:SMMT |
Biotechnology | 36.07% |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Verona Pharma PLC ADR
NASDAQ:VRNA |
Biotechnology | 0.00% |
|
3SBio Inc
F:83B |
Biotechnology | 10.64% |
Shanghai Haohai Biological Tech Co Asset Resilience Ratio by Year (2012–2024)
Shanghai Haohai Biological Tech Co asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Shanghai Haohai Biological Tech Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.23% | CN¥87.85 Million ≈ $12.85 Million |
CN¥7.12 Billion ≈ $1.04 Billion |
+1.07pp |
| 2023-12-31 | 0.17% | CN¥11.76 Million ≈ $1.72 Million |
CN¥7.11 Billion ≈ $1.04 Billion |
+0.07pp |
| 2022-12-31 | 0.10% | CN¥6.75 Million ≈ $987.58K |
CN¥6.89 Billion ≈ $1.01 Billion |
+0.01pp |
| 2021-12-31 | 0.09% | CN¥6.38 Million ≈ $933.01K |
CN¥6.95 Billion ≈ $1.02 Billion |
-0.15pp |
| 2020-12-31 | 0.24% | CN¥15.14 Million ≈ $2.22 Million |
CN¥6.30 Billion ≈ $921.70 Million |
-1.59pp |
| 2018-12-31 | 1.83% | CN¥81.28 Million ≈ $11.89 Million |
CN¥4.44 Billion ≈ $649.18 Million |
+0.69pp |
| 2013-12-31 | 1.14% | CN¥7.09 Million ≈ $1.04 Million |
CN¥621.18 Million ≈ $90.90 Million |
-0.42pp |
| 2012-12-31 | 1.56% | CN¥7.00 Million ≈ $1.02 Million |
CN¥448.04 Million ≈ $65.56 Million |
-- |
About Shanghai Haohai Biological Tech Co
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more